Nobilis® Rismavac + CA126 is a combined live, cell-associated Marek’s Disease vaccine recommended for the immunisation of healthy chicks against Marek’s Disease. COMPOSITION Nobilis® Rismavac + CA126 is a combined live vaccine containing FC-126 (serotype 3) strain of Turkey Herpes Virus and CVI-988 (serotype 1) strain of Fowl Herpes Virus. CONTENTS Each dose of Nobilis® Rismavac + CA126 contains at least 3,0 log10 PFU of live Turkey Herpes Virus strain FC-126 (serotype 3) and at least 3,0 log10 PFU of live Fowl Herpes Virus strain CVI-988 (serotype 1) in the cell-associated form, as a suspension of virus containing SPF chicken embryo fibroblasts.